Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna Roder

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
BMC Bioinformatics|May 19, 2019
Improving the power of gene set enrichment analysesJoanna Roder, Benjamin Linstid, Carlos Oliveira
BMC Medical Informatics and Decision Making|July 9, 2021
Explaining multivariate molecular diagnostic tests via Shapley valuesJoanna Roder, Laura Maguire, Robert Georgantas, et al.
BMC Bioinformatics|June 15, 2019
A dropout-regularized classifier development approach optimized for precision medicine test discovery from omics dataJoanna Roder, Carlos Oliveira, Lelia Net, et al.
BMC Bioinformatics|May 30, 2019
Robust identification of molecular phenotypes using semi-supervised learningHeinrich Roder, Carlos Oliveira, Lelia Net, et al.
International Journal of Molecular Sciences|February 5, 2020
Mass Spectrometry-Based Multivariate Proteomic Tests for Prediction of Outcomes on Immune Checkpoint Blockade Therapy: The Modern Analytical ApproachJulia Grigorieva, Senait Asmellash, Lelia Net, et al.
Molecules (Basel, Switzerland)|February 15, 2022
Semi-Quantitative MALDI Measurements of Blood-Based Samples for Molecular DiagnosticsMatthew A Koc, Senait Asmellash, Patrick Norman, et al.
Cellular & Molecular Immunology|January 25, 2011
In situ mass spectrometry of autoimmune liver diseasesChristopher L Bowlus, Erin H Seeley, Joanna Roder, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
A retrospective analysis of VeriStrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancerThomas E Stinchcombe, Joanna Roder, Amy H Peterman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trialDavid P Carbone, Keyue Ding, Heinrich Roder, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|November 25, 2021
A proposal for score assignment to characterize biological processes from mass spectral analysis of serumJoanna Roder, Lelia Net, Carlos Oliveira, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
BMC Bioinformatics|May 19, 2019
Improving the power of gene set enrichment analysesJoanna Roder, Benjamin Linstid, Carlos Oliveira
BMC Medical Informatics and Decision Making|July 9, 2021
Explaining multivariate molecular diagnostic tests via Shapley valuesJoanna Roder, Laura Maguire, Robert Georgantas, et al.
BMC Bioinformatics|June 15, 2019
A dropout-regularized classifier development approach optimized for precision medicine test discovery from omics dataJoanna Roder, Carlos Oliveira, Lelia Net, et al.
BMC Bioinformatics|May 30, 2019
Robust identification of molecular phenotypes using semi-supervised learningHeinrich Roder, Carlos Oliveira, Lelia Net, et al.
International Journal of Molecular Sciences|February 5, 2020
Mass Spectrometry-Based Multivariate Proteomic Tests for Prediction of Outcomes on Immune Checkpoint Blockade Therapy: The Modern Analytical ApproachJulia Grigorieva, Senait Asmellash, Lelia Net, et al.
Molecules (Basel, Switzerland)|February 15, 2022
Semi-Quantitative MALDI Measurements of Blood-Based Samples for Molecular DiagnosticsMatthew A Koc, Senait Asmellash, Patrick Norman, et al.
Cellular & Molecular Immunology|January 25, 2011
In situ mass spectrometry of autoimmune liver diseasesChristopher L Bowlus, Erin H Seeley, Joanna Roder, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
A retrospective analysis of VeriStrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancerThomas E Stinchcombe, Joanna Roder, Amy H Peterman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trialDavid P Carbone, Keyue Ding, Heinrich Roder, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|November 25, 2021
A proposal for score assignment to characterize biological processes from mass spectral analysis of serumJoanna Roder, Lelia Net, Carlos Oliveira, et al.
Pageof 3